Cannabinoid Receptors and AD: Searching Beyond the Simple Story
Researchers from Spain describe changes in cannabinoid receptors in the brains of AD patients, as well as...
6397 RESULTS
Sort By:
Researchers from Spain describe changes in cannabinoid receptors in the brains of AD patients, as well as...
Immune molecules, thought to act exclusively in the periphery presenting antigens and fighting infection, in fact, have an alter ego in the brain's neurons, where they help remodel synapses in response to neural activity. How's this for a wild idea in AD research: Could it be that synapses are attacked in a misguided immune response...
Venturing off the beaten path, <strong>Bryce Carey</strong> yesterday presented a poster at the Society for Neuroscience meeting about the interaction...
This is the third installment of a four-part news series about the role of the microtubule-associated protein tau from the 35th Annual Conference of the Society for Neuroscience...
When it works properly, the endoplasmic reticulum (ER) constantly pumps out newly synthesized membrane proteins, perfectly folded and sorted to their proper cellular destination...
Mutations in Pink1, a gene coding for a mitochondrial protein kinase, has just been fingered as a genetic cause for parkinsonism. In today’s Sciencexpress, researchers report that Pink1 and PARK6, a long-sought-after genetic locus that is linked with early-onset Parkinson’s disease, are...
In today's SciencExpress, researchers from Italy, France, and The Netherlands report that mutations in DJ-1, a protein of unknown function, can lead to Parkinson's disease...
Biochemists, cell and molecular biologists, start your engines! You now have another Parkinson protein challenge...
In last October’s Neuron, researchers revealed that the gene LRRK2, encoding a protein kinase dubbed “dardarin,” is one and the same with...
This is Part 1 of a three-part report. See also <a href="/news/conference-coverage/madrid-pooled-antibody-cocktail-new-metal-quencher">Part 2</a> and <a href="/news/conference-coverage/madrid-highs-and-lows-insulin-connection">Part 3</a> of this report.
This is Part 2 of a three-part report. See also <a href="/news/conference-coverage/madrid-clinical-trials-update-where-do-things-stand">Intro/Part 1</a> and <a href="/news/conference-coverage/madrid-highs-and-lows-insulin-connection">Part 3</a> of this clinical trials update.
This month’s Archives of Neurology provides a gold mine of studies on the neuropathological correlates of...
This is Part 3 of a three-part report. See also <a href="/news/conference-coverage/madrid-clinical-trials-update-where-do-things-stand">Intro/Part 1</a> and <a href="/news/conference-coverage/madrid-pooled-antibody-cocktail-new-metal-quencher">Part 2</a> of this clinical trials update. Also see <a href="/sites/default/files/legacy/images/new/TrialsUpdate1458.pdf" target="_new">PDF</a> of Part 3.
A newcomer has joined the ranks of suspects implicated in early Alzheimer's disease. In tomorrow's Nature, Li-Huei Tsai of Harvard Medical School and her colleagues report that the protein p25 deregulates the kinase cdk5...
What, exactly, is the trigger for Alzheimer’s disease? Is there one such thing? At today’s annual meeting of the American Society for Biochemistry and Molecular Biology...
No filters selected